Mark Cragg, PhD

Chair in Experimental Cancer Biology at University of Southampton

Speaker

Mark Cragg is Professor of Experimental Cancer Biology in the School of Cancer Sciences at the University of Southampton. His research concerns how therapeutics result in tumour regression with a focus on antibodies and small molecules, with a particular interest in Fc receptors and TNFR family members. The aim is to understand how these therapeutics delete tumour cells, how resistance occurs, and how it might be overcome.